Interest in {dimethyltryptamine | copyright | this substance ) is increasingly fueling a growing dialogue across Canada. Formerly viewed as the fringes of research , copyright is now finding greater scrutiny from scientists , clinicians, and the community. Legislative policies surrounding its pro